Polyclonal Antibody conjugated to agarose of Gel: 200 µl targeting DDDDK-tag for IP.
| Product Specifications | |
| Application | IP |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | Synthetic peptide binding KLH, DYKDDDDK |
| Formulation | 320 μg of anti-DDDDK-tag polyclonal antibody covalently coupled to 200 μl of agarose gel and provided as a 50% gel slurry suspended in PBS containing preservative (0.09% sodium azide) for a total volume of 400 μl. *Azide may react with copper or lead in plumbing system to form explosive metal azides. Therefore, always flush plenty of water when disposing materials containing azide into drain. |
| Citations for Anti-DDDDK-tag pAb-Agarose – 4 Found |
| Kato, Kiyoko; Nakajima, Kazuhiro; Ui, Ayako; Muto-Terao, Yuri; Ogiwara, Hideaki; Nakada, Shinichiro. Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice. Molecular Cell. 2014;53(4):617-30. PubMed - Comments: Used in: IP |
| Jing, Hongwei; Yang, Xiaolu; Zhang, Jian; Liu, Xuehui; Zheng, Huakun; Dong, Guojun; Nian, Jinqiang; Feng, Jian; Xia, Bin; Qian, Qian; Li, Jiayang; Zuo, Jianru. Peptidyl-prolyl isomerization targets rice Aux/IAAs for proteasomal degradation during auxin signalling. Nature Communications. 2015;6:7395. PubMed - Comments: Used in: IP |
| Han, Yingyan; Wu, Peng; Wang, Zhi; Zhang, Zeyu; Sun, Shujuan; Liu, Jia; Gong, Song; Gao, Peipei; Iwakuma, Tomoo; Molina-Vila, Miguel Angel; Chen, Benjamin Ping-Chi; Zhang, Yu; Ji, Teng; Mo, Qingqing; Chen, Pingbo; Hu, Junbo; Wang, Shixuan; Zhou, Jianfeng; Lu, Hua; Gao, Qinglei. Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation. Ebiomedicine. 2019;40:92-105. PubMed - Comments: Used in: IP |
| Sun, Huiyuan; Ling, Shukuan; Zhao, Dingsheng; Li, Jianwei; Li, Yang; Qu, Hua; Du, Ruikai; Zhang, Ying; Xu, Feng; Li, Yuheng; Liu, Caizhi; Zhong, Guohui; Liang, Shuai; Liu, Zizhong; Gao, Xingcheng; Jin, Xiaoyan; Li, Yingxian; Shi, Dazhuo. Ginsenoside Re Treatment Attenuates Myocardial Hypoxia/Reoxygenation Injury by Inhibiting HIF-1α Ubiquitination. Frontiers In Pharmacology. 11:532041. PubMed - Comments: Used in: IP |